CytoSorbents Corp (CTSO)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$0.92

Buy

$1.02

arrow-down$-0.01 (-1.00%)

CytoSorbents Corp is a immunotherapy company. The Company uses blood purification to modulate inflammation with the goal of preventing or treating multiple organ failure in life-threatening illnesses and cardiac surgery.
Prices updated at 03 Apr 2025, 12:00 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-down-5.97%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$1.02 - $0.98
$1.61 - $0.70
-
61.72m
-
-
51,263
5.57
144,494.04
1.70
54.83m
US23283X2062
-0.38
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.